Call 855-808-4530 or email [email protected] to receive your discount on a new subscription.
By and large, the FDA has confined its participation to cases where it had specifically considered ' and rejected ' the plaintiffs' claims that a product's labeling or advertising should have included different language from that which was used. See Daniel E. Troy, FDA Involvement in Product Liability Lawsuits, Update: Food & Drug. L., Reg. & Educ. (Food & Drug Law Inst., Wash., D.C.), Jan./Feb. 2003, at 1. In 2004, however, the FDA submitted a brief in a state products liability action that signals the agency's willingness to be much more aggressive in protecting its jurisdiction from lay judge and jury determinations concerning a product's risk-benefit balance that conflict with the FDA's own determination of where that balance lies. See Br. of Amicus Curiae U.S. Dep't of Justice, Horn v. Thoratec Corp., 376 F.3d 163 (3d Cir. 2004) (No. 02-4597) (“FDA Br.”).
Background
The medical device at issue in Horn was a HeartMate heart pump. After extensive review and numerous communications with the manufacturer, the FDA approved the pump in 1994 pursuant to the Pre-Market Approval (“PMA”) process set forth in 21 U.S.C. '360e(c). See Horn v. Thoratec Corp., 376 F. 3d 163, 164-65, 169-70 (3d Cir. 2004). The plaintiff brought design defect and failure to warn claims against the device manufacturer following her husband's death a few days after the HeartMate implanted into him became disconnected from his heart. Id. at 165. The district court granted summary judgment in favor of the device manufacturer, finding that such claims were pre-empted by the Medical Device Amendments' (“MDA's”) express pre-emption provision set forth in 21 U.S.C. '360k(a). Id. That provision prohibits states from establishing or maintaining any safety or effectiveness requirement for a medical device that is “different from, or in addition to, any requirement applicable” under the FDCA. 21 U.S.C. '360k(a)(1). The plaintiff appealed the ruling to the U.S. Court of Appeals for the Third Circuit. Horn, 376 F.3d at 165.
ENJOY UNLIMITED ACCESS TO THE SINGLE SOURCE OF OBJECTIVE LEGAL ANALYSIS, PRACTICAL INSIGHTS, AND NEWS IN ENTERTAINMENT LAW.
Already a have an account? Sign In Now Log In Now
For enterprise-wide or corporate acess, please contact Customer Service at [email protected] or 877-256-2473
This article highlights how copyright law in the United Kingdom differs from U.S. copyright law, and points out differences that may be crucial to entertainment and media businesses familiar with U.S law that are interested in operating in the United Kingdom or under UK law. The article also briefly addresses contrasts in UK and U.S. trademark law.
With each successive large-scale cyber attack, it is slowly becoming clear that ransomware attacks are targeting the critical infrastructure of the most powerful country on the planet. Understanding the strategy, and tactics of our opponents, as well as the strategy and the tactics we implement as a response are vital to victory.
The Article 8 opt-in election adds an additional layer of complexity to the already labyrinthine rules governing perfection of security interests under the UCC. A lender that is unaware of the nuances created by the opt in (may find its security interest vulnerable to being primed by another party that has taken steps to perfect in a superior manner under the circumstances.
In Rockwell v. Despart, the New York Supreme Court, Third Department, recently revisited a recurring question: When may a landowner seek judicial removal of a covenant restricting use of her land?